EUVIMEDEUVIMED entdecken
Systematische Übersicht

Pruritus in cutaneous graft‐versus‐host disease: A systematic review

Jie Zhu iD, Alexander A Navarini iD, Joerg P Halter, Simon M Mueller iD

Journal of the European Academy of Dermatology and Venereology · 2023-07 · 37 (7) · 1276-1283

DOI: 10.1111/jdv.19057 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 05.04.2023. Verfasst von Jie Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Skin Diseases, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Gottfried und Julia Bangerter-Rhyner-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pruritus is a common symptom of cutaneous graft‐versus‐host disease (GVHD) following haematopoietic stem cell transplantation (HSCT). However, little is known about its prevalence, pathophysiology, perceptual characteristics, impact on quality of life and response to antipruritic therapies. The aim of this review was to determine the current knowledge on pruritus in cutaneous GVHD. The review was conducted according to the Preferred Reporting Items for Systematic Review and Meta‐Analyses statement. Of the 338 studies screened, 13 were included. The prevalence of pruritus in cutaneous GVHD was reported in three studies, ranging from 37.0% to 63.8%. Only four trials used pruritus assessment tools. There was little or no information on the intensity of pruritus, its qualitative perception, the location of pruritus and the impact of pruritus on quality of life. Antipruritic treatments for GVHD‐associated pruritus were mentioned in five studies (38.5%), including topical ointments (steroids, tacrolimus and calcipotriene), broadband UVB, systemic antihistamines and oral ursodeoxycholic acid. In conclusion, pruritus in cutaneous GVHD appears to be common, but very little is known about the pathophysiology, impact on quality of life and effective treatment options. Basic research and controlled clinical trials are warranted to improve knowledge and management of this important issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin DiseasesGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansAntipruriticsQuality of LifePruritus

Substanzen

Antipruritics

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Department of Haematology, University Hospital Basel, Basel, Switzerland.

ORCID-Profile: Jie Zhu, Alexander A Navarini, Simon M Mueller

Förderung

  • Gottfried und Julia Bangerter-Rhyner-Stiftung

Zitieren

APA

Zhu, J., Navarini, A. A., Halter, J. P., & Mueller, S. M. (2023). Pruritus in cutaneous graft‐versus‐host disease: A systematic review. Journal of the European Academy of Dermatology and Venereology, 37(7), 1276-1283. https://doi.org/10.1111/jdv.19057

Vancouver

Zhu J, Navarini AA, Halter JP, Mueller SM. Pruritus in cutaneous graft‐versus‐host disease: A systematic review. Journal of the European Academy of Dermatology and Venereology. 2023;37(7):1276-1283. doi:10.1111/jdv.19057

BibTeX
@article{Zhu2023,
  author = {Zhu, Jie and Navarini, Alexander A and Halter, Joerg P and Mueller, Simon M},
  title = {Pruritus in cutaneous graft‐versus‐host disease: A systematic review},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  volume = {37},
  number = {7},
  pages = {1276--1283},
  doi = {10.1111/jdv.19057}
}
Kostenlos starten →